Related Experiment Video
Updated: Sep 7, 2025

Preparation of 3D Decellularized Matrices from Fetal Mouse Skeletal Muscle for Cell Culture
Published on: March 3, 2023
The most severe form of LMNA-associated congenital muscular dystrophy
Yuka Murofushi1, Itaru Hayakawa1, Yuichi Abe1
1Division of Neurology, National Center for Child Health and Development (NCCHD), 2-10-1 Okura, Setagaya-ku, Tokyo 157-8535, Japan.
Insights
LMNA gene mutations cause laminopathies, including a severe congenital muscular dystrophy case with early-onset cardiac issues. Early genetic testing is crucial for identifying cardiac risks in these patients.
Area of Science:
- Genetics
- Molecular Biology
- Cardiology
Background:
- LMNA gene mutations lead to laminopathies, a group of disorders.
- LMNA-associated congenital muscular dystrophy typically presents with infantile muscle weakness and developmental delays.
Observation:
- A case of LMNA-associated congenital muscular dystrophy presented with severe symptoms in the first decade.
- The patient exhibited head control and facial muscle weakness, with cardiac dysrhythmias at age 5.
- Dilated cardiomyopathy and ischemic strokes occurred at age 7, leading to sudden death at age 9.
Findings:
- This case demonstrates a severe phenotype of LMNA-associated congenital muscular dystrophy with early cardiac involvement.
- Cardiac symptoms, rare in the first decade, were prominent in this patient.
Implications:
- This case broadens the known phenotypic spectrum of LMNA-related disorders.
- Highlights the importance of early LMNA genetic testing in congenital muscular dystrophy for cardiac screening and timely intervention.
Abstract:
Alterations in the LMNA gene cause a wide spectrum of diseases collectively called laminopathies. LMNA-associated congenital muscular dystrophy is a form of laminopathy, which usually causes infantile onset of muscle weakness, predominantly in the cervical-axial muscles, and motor developmental retardation. Cardiac symptoms during the first decade of life are rare. We report a case of LMNA-associated congenital muscular dystrophy in which the patient did not achieve head control and experienced facial muscle weakness. Cardiac dysrhythmias were observed at 5 years with development of dilated cardiomyopathy and ischemic strokes at 7 years. Despite intensive medical intervention, he died suddenly at 9 years. This report broadens the spectrum of phenotypes of this disorder with the most severe symptoms during the first decade of life. Our case underscores the need for early genetic testing for LMNA in patients with congenital muscular dystrophy to screen for cardiac manifestations and intervene as necessary.
Related Concept Videos
Satellite Stem Cells and Muscular Dystrophy
Disorders of the Skeletal Muscle
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cross-bridge Cycle
Myasthenia Gravis: Overview and Treatment
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
Myasthenia Gravis: Diagnostic Tests
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...

